您的位置: 首页 > 农业专利 > 详情页

СПОСОБ ПРОГНОЗИРОВАНИЯ МАССИВНОЙ ИНТРАОПЕРАЦИОННОЙ КРОВОПОТЕРИ ПРИ ОПЕРАЦИЯХ ПО ПОВОДУ НЕОРГАННЫХ ЗАБРЮШИННЫХ ОПУХОЛЕЙ
专利权人:
FEDERALNOE GOSUDARSTVENNOE BJUDZHETNOE UCHREZHDENIE "ROSTOVSKIJ NAUCHNO-ISSLEDOVATELSKIJ ONKOLOGICHESKIJ INSTITUT" MINISTERSTVA ZDRAVOOKHRANENIJA ROSSIJSKOJ FEDERATSII (FGBU "RNIOI" MINZDRAVA ROSSII)
发明人:
KIT OLEG IVANOVICH,Кит Олег Иванович,KASATKIN VADIM FEDOROVICH,Касаткин Вадим Федорович,MAKSIMOV ALEKSEJ JUREVICH,Максимов Алексей Юрьевич,MOROSHAN ALEKSEJ NIKOLAEVICH,Морошан Алексей Николаевич
申请号:
RU2011152427/14
公开号:
RU0002489087C1
申请日:
2011.12.21
申请国别(地区):
RU
年份:
2013
代理人:
摘要:
FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to surgery, anesthesiology and intensive therapy, oncology, and can be applied in operations on account of non-organ retroperitoneal tumours. For this purpose prognostic criteria are determined on the basis of clinical and anamnestic parameters: Long stands for longitudinal dimension of tumour, in cm Transv stands for transverse dimension of tumour, in cm Rad stands for radical character of operation: 1 point means presence of radical intervention 0 points means absence, palliative surgery, exploratory laparotomy AddRes means carrying out additional resection of organs: 1 point means presence of organ resection 0 points means operation only on tumour ablation PorS stands for surgery on main vessels: 1 point stands for vascular plasty of arteries, resection of fragments of inferior vena cava, aorta DifG stands for diffusion growth of tumour without capsulation: 1 point means presence 0 points means absence. After that, coefficient of regression Z is calculated: Z=-0.581+0.038×Long+0.02×Transv+0.073×Rad+0.166×AddRes+0.133×PorS+0.102×DifG and substituted into formula: P1=11+e−(1,2−4,18×Z) where e is base of natural logarithm with value e=2.72. If P1 constitutes from 0.87 to 0.26, massive intraoperative blood loss, requiring increased dose of colloids, but not more than 40 ml/kg/day in carrying out infusion therapy, is predicted.EFFECT: method makes it possible to select optimal tactics of compensation of intravascular volume of colloids in operations in said category of patients due to more accurate calculation of blood loss volume.1 exИзобретение относится к медицине, а именно к хирургии, анестезиологии и интенсивной терапии, онкологии, и может быть использовано при операциях по поводу неорганных забрюшинных опухолей. Для этого определяют прогностические критерии на основании клинико-анамнестических показателей: Прод - продольный размер опухоли в см Попер - поперечный размер опухоли в см Рад - радикальн
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充